Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Gt Biopharma (0RU9)

Gt Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0RU9
DateTimeSourceHeadlineSymbolCompany
12/09/201912:30PR Newswire (US)GT Biopharma Announces FDA Notification of Commencement of Enrollment in Human GTB-3550 Trike™ Phase i/ii Clinical TrialLSE:0RU9Gt Biopharma Inc
12/09/201912:30PR Newswire (US)GT Biopharma Announces FDA Notification of Commencement of Enrollment in Human GTB-3550 Trike™ Phase i/ii Clinical TrialLSE:0RU9Gt Biopharma Inc
13/06/201912:30PR Newswire (US)GT Biopharma GTB-1550LSE:0RU9Gt Biopharma Inc
13/06/201912:30PR Newswire (US)GT Biopharma GTB-1550LSE:0RU9Gt Biopharma Inc
29/05/201912:30PR Newswire (US)GT Biopharma GTB-1550 PHASE I-II Results to be Published in Conjunction With 2019 ASCO Meeting May 31 - June 4 in ChicagoLSE:0RU9Gt Biopharma Inc
29/05/201912:30PR Newswire (US)GT Biopharma GTB-1550 PHASE I-II Results to be Published in Conjunction With 2019 ASCO Meeting May 31 - June 4 in ChicagoLSE:0RU9Gt Biopharma Inc
26/03/201911:30PR Newswire (US)GT Biopharma Announces Completion of Management RestructuringLSE:0RU9Gt Biopharma Inc
30/08/201813:00PR Newswire (US)GT Biopharma's Chairman and Chief Executive Officer Raymond W Urbanski, M.D., Ph.D Provides Insight Into the Impact of the Re...LSE:0RU9Gt Biopharma Inc
29/08/201812:45PR Newswire (US)GT Biopharma's Chairman and Chief Executive Officer Provides Insight Into the Impact of the Recent Affimed/Roche-Genetech Col...LSE:0RU9Gt Biopharma Inc
24/08/201813:00PR Newswire (US)GT Biopharma Announces the Appointment of David Cardino, CPA, MBA as Vice President of FinanceLSE:0RU9Gt Biopharma Inc
14/08/201813:00PR Newswire (US)GT Biopharma Announces GTBP CEO, Dr. Raymond Urbanski, to Make Presentation at the 2018 Wedbush PacGrow Healthcare ConferenceLSE:0RU9Gt Biopharma Inc
25/07/201813:00PR Newswire (US)GT Biopharma Announces the Addition of Dr. John N. Bonfiglio to its Board of DirectorsLSE:0RU9Gt Biopharma Inc
19/07/201813:00PR Newswire (US)GT Biopharma Inc. Announces Agreement with a Major Pharmaceutical Company to Study its Drug Candidate OXS-1550 in Combination...LSE:0RU9Gt Biopharma Inc
05/06/201813:00PR Newswire (US)GT Biopharma Announces Voluntary Lock-Up Agreements With Insiders Covering Over 52% of Outstanding SharesLSE:0RU9Gt Biopharma Inc
14/05/201812:45PR Newswire (US)Gt Biopharma Announces Dr. Raymond W Urbanski Elevated to President and Chief Medical Officer of the CompanyLSE:0RU9Gt Biopharma Inc
26/04/201813:30PR Newswire (US)Seasoned Financial Executive Federica O'Brien Joins GT Biopharma's Board of DirectorsLSE:0RU9Gt Biopharma Inc
24/04/201814:15PR Newswire (US)Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of DirectorsLSE:0RU9Gt Biopharma Inc
29/03/201814:05PR Newswire (US)GT Biopharma Inc. Announces >50% Enrollment in Proof-Of-Concept Clinical Trial For Its Novel Treatment For Motion SicknessLSE:0RU9Gt Biopharma Inc
13/02/201812:45PR Newswire (US)GT Biopharma Announces Dr. Jeffrey Miller, Renowned NK Cell Cancer Specialist, Will Present at Cell Therapy SymposiaLSE:0RU9Gt Biopharma Inc
24/01/201813:39PR Newswire (US)GT Biopharma, Inc. Issues Letter to ShareholdersLSE:0RU9Gt Biopharma Inc
18/12/201715:27PR Newswire (US)GT Biopharma, Inc. Files Application for NASDAQ Capital Market ListingLSE:0RU9Gt Biopharma Inc
 Showing the most relevant articles for your search:LSE:0RU9